Search

Author/Creator Cassoux, N.

1. Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma. (December 2016)

Authors:
Carita, G.; Frisch-Dit-Leitz, E.; Dahmani, A.; Raymondie, C.; Cassoux, N.; Piperno-Neumann, S.; Némati, F.; Laurent, C.; De Koning, L.; Halilovic, E.; Jeay, S.; Wylie, A.; Emery, C.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. IBRUTINIB IN RELAPSE OR REFRACTORY PRIMARY CNS AND VITREO‐RETINAL LYMPHOMA. RESULTS OF THE PRIMARY END‐POINT OF THE ILOC PHASE II STUDY FROM THE LYSA AND THE FRENCH LOC NETWORK. (June 2017)

Authors:
Soussain, C.; Choquet, S.; Houillier, C.; Bijou, F.; Houot, R.; Boyle, E.; Gressin, R.; Nicolas‐Virelizier, E.; Barrie, M.; Moluçon‐Chabrot, C.; Lelez, M.; Clavert, A.; Coisy, S.; de la Bretonnière, M. Ertault; El Yamani, A.; Touitou, V.; Cassoux, N.; Boussetta, S.; Broussais, F.; Gelas‐Dore, B.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
72
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II 'proof-of-concept' iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network. (August 2019)

Authors:
Soussain, C.; Choquet, S.; Blonski, M.; Leclercq, D.; Houillier, C.; Rezai, K.; Bijou, F.; Houot, R.; Boyle, E.; Gressin, R.; Nicolas-Virelizier, E.; Barrie, M.; Moluçon-Chabrot, C.; Lelez, M.L.; Clavert, A.; Coisy, S.; Leruez, S.; Touitou, V.; Cassoux, N.; Daniau, M.
Journal:
European journal of cancer
Issue:
Volume 117(2019)
Page Start:
121
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. TEMOZOLOMIDE IN RELAPSE/REFRACTORY PRIMARY VITREO‐RETINAL LYMPHOMA (R/R PVRL): A SIMPLE, CHEAP, EFFECTIVE AND WELL TOLERATED TREATMENT. RESULT OF THE LARGEST STUDY ON R/R PVRL, FROM THE LOC NETWORK. (12th June 2019)

Authors:
Choquet, S.; Baron, M.; Soussain, C.; Houillier, C.; Gyan, E.; Soubeyran, P.; Cassoux, N.; Touitou, V.; Bodaghi, B.; Hoang‐Xuan, K.; Leblond, V.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
269
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗